1389 related articles for article (PubMed ID: 33363049)
1. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 - gastrointestinal and gut microbiota-related aspects.
Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
4. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 on the Gut: A Review of the Manifestations, Pathology, Management, and Challenges.
Suryana KD; Simadibrata M; Renaldi K
Acta Med Indones; 2021 Jan; 53(1):96-104. PubMed ID: 33818412
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
[TBL] [Abstract][Full Text] [Related]
8. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients.
Soltani S; Zakeri A; Zandi M; Kesheh MM; Tabibzadeh A; Dastranj M; Faramarzi S; Didehdar M; Hafezi H; Hosseini P; Farahani A
Biomed Res Int; 2021; 2021():6670798. PubMed ID: 33681368
[TBL] [Abstract][Full Text] [Related]
9. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
[TBL] [Abstract][Full Text] [Related]
10. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
[TBL] [Abstract][Full Text] [Related]
12. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
[TBL] [Abstract][Full Text] [Related]
13. Severe acute respiratory syndrome coronavirus-2 infection and the gut-liver axis.
Mohandas S; Vairappan B
J Dig Dis; 2020 Dec; 21(12):687-695. PubMed ID: 33099897
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
[TBL] [Abstract][Full Text] [Related]
16. Considerations for Gut Microbiota and Probiotics in Patients with Diabetes Amidst the Covid-19 Pandemic: A Narrative Review.
Barengolts E; Smith ED
Endocr Pract; 2020 Oct; 26(10):1186-1195. PubMed ID: 33471720
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms.
Settanni CR; Ianiro G; Ponziani FR; Bibbò S; Segal JP; Cammarota G; Gasbarrini A
World J Gastroenterol; 2021 Nov; 27(43):7433-7445. PubMed ID: 34887641
[TBL] [Abstract][Full Text] [Related]
18. The gut microbiome: a missing link in understanding the gastrointestinal manifestations of COVID-19?
Brooks EF; Bhatt AS
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33593727
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal symptoms associated with COVID-19: impact on the gut microbiome.
Villapol S
Transl Res; 2020 Dec; 226():57-69. PubMed ID: 32827705
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota Status in COVID-19: An Unrecognized Player?
Donati Zeppa S; Agostini D; Piccoli G; Stocchi V; Sestili P
Front Cell Infect Microbiol; 2020; 10():576551. PubMed ID: 33324572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
